Back
  • ePoster
  • eP121

Fernmetastasen-freies Überleben mit Pembrolizumab versus Placebo als adjuvante Therapie im Stadium IIB oder IIC Melanom: die Phase III KEYNOTE-716 Studie

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
ePoster 11

Session

Melanom

Topics

  • Experimentelle Dermato-Onkologie
  • Klinische Dermato-Onkologie: Melanom

Authors

Prof. Georgina V. Long (Sydney / AU), Jason Luke (Pittsburgh, PA / US), Muhammad A. Khattak (Perth / AU), Luis de la Cruz Merino (Seville / ES), Michele Del Vecchio (Milano / IT), Piotr Rutkowski (Warsaw / PL), Francesco Spagnolo (Genoa / IT), Jacek Mackiewicz (Poznan / PL), Vanna Chiarion-Sileni (Padova / IT), John M. Kirkwood (Pittsburgh, PA / US), Caroline Robert (Villejuif / FR), Jean-Jacques Grob (Marseille / FR), Federica de Galitiis (Rome / IT), Prof. Dr. med. Dirk Schadendorf (Essen / DE), Matteo S. Carlino (Sydney / AU), Larry Wu (Kenilworth, NJ / US), Mizuho Fukunaga-Kalabis (Kenilworth, NJ / US), Clemens Krepler (Kenilworth, NJ / US), Alexander M. M. Eggermont (Utrecht / NL), Dr. Paolo A. Ascierto (Naples / IT)

    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy